United States · FDA National Drug Code directory
Erlotinib Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72205-081_4cff04f5-3693-4d87-a9f8-a2b195e3d26e
- Product NDC
- 72205-081
- Form
- TABLET, FILM COATED
- Composition / generic term
- Erlotinib Hydrochloride
- Labeler
- Novadoz Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210511
- Source listing expiry
- 20261231
Source-listed ingredients
- ERLOTINIB HYDROCHLORIDE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (72205-081-30) / 30 TABLET, FILM COATED in 1 BOTTLE · 72205-081-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →